Cargando…

Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens

BACKGROUND: Extra-genital Neisseria gonorrhoeae and Chlamydia trachomatis infections are mostly asymptomatic, and important reservoir sites of infection as they often go undetected and may be more difficult to eradicate with recommended therapeutic regimens. Commercial nucleic acid amplification tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Venter, Johanna M. E., Mahlangu, Precious M., Müller, Etienne E., Lewis, David A., Rebe, Kevin, Struthers, Helen, McIntyre, James, Kularatne, Ranmini S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318993/
https://www.ncbi.nlm.nih.gov/pubmed/30606127
http://dx.doi.org/10.1186/s12879-018-3629-0
_version_ 1783384988736028672
author Venter, Johanna M. E.
Mahlangu, Precious M.
Müller, Etienne E.
Lewis, David A.
Rebe, Kevin
Struthers, Helen
McIntyre, James
Kularatne, Ranmini S.
author_facet Venter, Johanna M. E.
Mahlangu, Precious M.
Müller, Etienne E.
Lewis, David A.
Rebe, Kevin
Struthers, Helen
McIntyre, James
Kularatne, Ranmini S.
author_sort Venter, Johanna M. E.
collection PubMed
description BACKGROUND: Extra-genital Neisseria gonorrhoeae and Chlamydia trachomatis infections are mostly asymptomatic, and important reservoir sites of infection as they often go undetected and may be more difficult to eradicate with recommended therapeutic regimens. Commercial nucleic acid amplification tests (NAATs) have not received regulatory approval for the detection of N. gonorrhoeae and C. trachomatis in extra-genital specimens. The HOLOGIC® APTIMA Combo2 assay for N. gonorrhoeae and C. trachomatis has performed well in evaluations using extra-genital specimens. METHODS: We assessed the performance of an in-house real-time duplex PCR assay for the detection of N. gonorrhoeae and C. trachomatis in urine and extra-genital specimens using the HOLOGIC® APTIMA assays as gold standard comparators. Urine, oropharyngeal and ano-rectal specimens were collected from each of 200 men-who-have-sex-with-men (MSM) between December 2011 and July 2012. RESULTS: For N. gonorrhoeae detection, the in-house PCR assay showed 98.5–100% correlation agreement with the APTIMA assays, depending on specimen type. Sensitivity for N. gonorrhoeae detection was 82.4% for ano-rectal specimens, 83.3% for oropharyngeal specimens, and 85.7% for urine; and specificity was 100% with all specimen types. The positive predictive value (PPV) for N. gonorrhoeae detection was 100% and the negative predictive value (NPV) varied with sample type, ranging from 98.5–99.5%. For C. trachomatis detection, correlation between the assays was 100% for all specimen types. The sensitivity, specificity, PPV and NPV of the in-house PCR assay was 100% for C. trachomatis detection, irrespective of specimen type. CONCLUSION: The in-house duplex real-time PCR assay showed acceptable performance characteristics in comparison with the APTIMA® assays for the detection of extra-genital N. gonorrhoeae and C. trachomatis.
format Online
Article
Text
id pubmed-6318993
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63189932019-01-08 Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens Venter, Johanna M. E. Mahlangu, Precious M. Müller, Etienne E. Lewis, David A. Rebe, Kevin Struthers, Helen McIntyre, James Kularatne, Ranmini S. BMC Infect Dis Research Article BACKGROUND: Extra-genital Neisseria gonorrhoeae and Chlamydia trachomatis infections are mostly asymptomatic, and important reservoir sites of infection as they often go undetected and may be more difficult to eradicate with recommended therapeutic regimens. Commercial nucleic acid amplification tests (NAATs) have not received regulatory approval for the detection of N. gonorrhoeae and C. trachomatis in extra-genital specimens. The HOLOGIC® APTIMA Combo2 assay for N. gonorrhoeae and C. trachomatis has performed well in evaluations using extra-genital specimens. METHODS: We assessed the performance of an in-house real-time duplex PCR assay for the detection of N. gonorrhoeae and C. trachomatis in urine and extra-genital specimens using the HOLOGIC® APTIMA assays as gold standard comparators. Urine, oropharyngeal and ano-rectal specimens were collected from each of 200 men-who-have-sex-with-men (MSM) between December 2011 and July 2012. RESULTS: For N. gonorrhoeae detection, the in-house PCR assay showed 98.5–100% correlation agreement with the APTIMA assays, depending on specimen type. Sensitivity for N. gonorrhoeae detection was 82.4% for ano-rectal specimens, 83.3% for oropharyngeal specimens, and 85.7% for urine; and specificity was 100% with all specimen types. The positive predictive value (PPV) for N. gonorrhoeae detection was 100% and the negative predictive value (NPV) varied with sample type, ranging from 98.5–99.5%. For C. trachomatis detection, correlation between the assays was 100% for all specimen types. The sensitivity, specificity, PPV and NPV of the in-house PCR assay was 100% for C. trachomatis detection, irrespective of specimen type. CONCLUSION: The in-house duplex real-time PCR assay showed acceptable performance characteristics in comparison with the APTIMA® assays for the detection of extra-genital N. gonorrhoeae and C. trachomatis. BioMed Central 2019-01-03 /pmc/articles/PMC6318993/ /pubmed/30606127 http://dx.doi.org/10.1186/s12879-018-3629-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Venter, Johanna M. E.
Mahlangu, Precious M.
Müller, Etienne E.
Lewis, David A.
Rebe, Kevin
Struthers, Helen
McIntyre, James
Kularatne, Ranmini S.
Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens
title Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens
title_full Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens
title_fullStr Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens
title_full_unstemmed Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens
title_short Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens
title_sort comparison of an in-house real-time duplex pcr assay with commercial hologic® aptima assays for the detection of neisseria gonorrhoeae and chlamydia trachomatis in urine and extra-genital specimens
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318993/
https://www.ncbi.nlm.nih.gov/pubmed/30606127
http://dx.doi.org/10.1186/s12879-018-3629-0
work_keys_str_mv AT venterjohanname comparisonofaninhouserealtimeduplexpcrassaywithcommercialhologicaptimaassaysforthedetectionofneisseriagonorrhoeaeandchlamydiatrachomatisinurineandextragenitalspecimens
AT mahlangupreciousm comparisonofaninhouserealtimeduplexpcrassaywithcommercialhologicaptimaassaysforthedetectionofneisseriagonorrhoeaeandchlamydiatrachomatisinurineandextragenitalspecimens
AT mulleretiennee comparisonofaninhouserealtimeduplexpcrassaywithcommercialhologicaptimaassaysforthedetectionofneisseriagonorrhoeaeandchlamydiatrachomatisinurineandextragenitalspecimens
AT lewisdavida comparisonofaninhouserealtimeduplexpcrassaywithcommercialhologicaptimaassaysforthedetectionofneisseriagonorrhoeaeandchlamydiatrachomatisinurineandextragenitalspecimens
AT rebekevin comparisonofaninhouserealtimeduplexpcrassaywithcommercialhologicaptimaassaysforthedetectionofneisseriagonorrhoeaeandchlamydiatrachomatisinurineandextragenitalspecimens
AT struthershelen comparisonofaninhouserealtimeduplexpcrassaywithcommercialhologicaptimaassaysforthedetectionofneisseriagonorrhoeaeandchlamydiatrachomatisinurineandextragenitalspecimens
AT mcintyrejames comparisonofaninhouserealtimeduplexpcrassaywithcommercialhologicaptimaassaysforthedetectionofneisseriagonorrhoeaeandchlamydiatrachomatisinurineandextragenitalspecimens
AT kularatneranminis comparisonofaninhouserealtimeduplexpcrassaywithcommercialhologicaptimaassaysforthedetectionofneisseriagonorrhoeaeandchlamydiatrachomatisinurineandextragenitalspecimens